KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Gains from Investment Securities (2016 - 2025)

Merck (MRK) has disclosed Gains from Investment Securities for 17 consecutive years, with -$397.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 796.49% to -$397.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$511.0 million, a 502.36% decrease, with the full-year FY2025 number at -$511.0 million, down 502.36% from a year prior.
  • Gains from Investment Securities was -$397.0 million for Q4 2025 at Merck, down from $330.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $330.0 million in Q3 2025 to a low of -$1.2 billion in Q4 2022.
  • A 5-year average of -$77.9 million and a median of -$5.5 million in 2021 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 4400.0% in 2022; the steepest drop was 1186.79% in 2022.
  • Merck's Gains from Investment Securities stood at $106.0 million in 2021, then tumbled by 1186.79% to -$1.2 billion in 2022, then surged by 96.09% to -$45.0 million in 2023, then surged by 226.67% to $57.0 million in 2024, then tumbled by 796.49% to -$397.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Gains from Investment Securities are -$397.0 million (Q4 2025), $330.0 million (Q3 2025), and -$335.0 million (Q2 2025).